Skip to content
DataLookout
Menu

Jazz Pharmaceuticals clinical trial pipeline

Get alerts when Jazz Pharmaceuticals's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19

What changed in the last 30 days

12 trials changed in the last 30 days: 0 stopped, 5 with notable changes, 7 with minor changes only.

  1. Notable: CBD-OS · DEE Recruitment opened Jazz PharmaceuticalsPhase 3 NCT07723976
  2. Minor: XYRISE · Xywav Expanded Dosing vs Placebo · Narcolepsy or IH Trial sites expanded: 15 → 27 locations Jazz PharmaceuticalsPhase 3 NCT07625280
  3. Minor: EmpowHER 208 · Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy · HER2-positive Breast Cancer Trial sites expanded: 53 → 60 locations Jazz PharmaceuticalsPhase 2 NCT07102381
  4. Notable: Lurbinectedin in Combination With Durvalumab · ES-SCLC Primary completion pushed from Jan 31, 2028 to Aug 4, 2029 Jazz PharmaceuticalsPhase 2 NCT07459634
  5. Notable: JZP269 in Healthy Male and Female Participants Recruitment opened Jazz PharmaceuticalsPhase 1 NCT07813663
  6. Minor: Zanidatamab · HER2-expressing Tumors Trial sites expanded: 28 → 42 locations Jazz PharmaceuticalsPhase 2 NCT06695845
  7. Minor: OPERA · Follow-Up of a Cohort of Participants Prescribed Epidyolex in France in a Real-life Setting Trial completed Jazz PharmaceuticalsNot specified NCT05772429
  8. Minor: JZP926 Capsule · Juvenile Myoclonic Epilepsy Trial sites expanded: 19 → 23 locations Jazz PharmaceuticalsPhase 2/3 NCT07723963
  9. Minor: JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma Trial sites expanded: 5 → 8 locations Jazz PharmaceuticalsPhase 2 NCT07533942
  10. Notable: ZOLA · Zanidatamab Outcomes and Lived Experiences in Advanced HER2+ GEA Start date pushed from Oct 1, 2026 to Nov 30, 2026 Jazz PharmaceuticalsNot specified NCT07780968
  11. Notable: Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms Primary completion pushed from Jul 2026 to Mar 31, 2027 Jazz PharmaceuticalsPhase 1 NCT04541082
  12. Minor: Food Effect of JZP047 in Healthy Participants Enrollment closed, study ongoing Jazz PharmaceuticalsPhase 1 NCT07377539
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

Active trials by phase

Phase 1
6
Phase 1/2
1
Phase 2
5
Phase 2/3
1
Phase 3
6
Phase 4
2
Not charted: 3 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 20

Get alerts when Jazz Pharmaceuticals's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free